Steven Gouge
Nephrology · San Antonio, TXNPI 1396729927
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for nephrology clinicians in TX, where the typical reported total is $1,420.
Across 77 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$329
- Veloxis Pharmaceuticals, Inc.$295
- Amgen$213
- Vifor Pharma, Inc.$183
- Mallinckrodt Enterprises LLC$151
- AstraZeneca$120
- plus $279 from 7 others
Across 82 payments — averaging $3611.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$128K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$106K
- AstraZeneca$40K
- Novo Nordisk AS$11K
- Baxter Healthcare$10K
- AbbVie$3K
What the payments were for
- Food & beverage$1,571100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $329 |
| Veloxis Pharmaceuticals, Inc. | 14 | $295 |
| Amgen | 7 | $213 |
| Vifor Pharma, Inc. | 11 | $183 |
| Mallinckrodt Enterprises LLC | 10 | $151 |
| AstraZeneca(2 entities) | 7 | $120 |
| Mallinckrodt Hospital Products Inc. | 5 | $112 |
| Johnson & Johnson | 3 | $58 |
| Leadiant Biosciences, Inc. | 2 | $39 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,571 in reported general payments places this provider in the 50th percentile of 1,070 nephrology providers in Texas.
Other nephrology in San Antonio
- Luis VelezSan Antonio$505K
- Rashid SharafSan Antonio$340K
- Carl DukesSan Antonio$238K
- Pablo PergolaSan Antonio$164K
- Varshasb BroumandSan Antonio$118K
- Shweta BansalSan Antonio$89K
- Rajeev NarayanSan Antonio$57K
- Anwar GergesSan Antonio$50K
- Matthew SchaeferSan Antonio$46K
- Kumar SharmaSan Antonio$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.